SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novartis -- Ignore unavailable to you. Want to Upgrade?


To: Sonki who wrote (95)11/7/1997 12:19:00 AM
From: Tom Wilkes  Respond to of 296
 
No, Sonki, I am not in yet, but I HAVE decided to put Novartis on my permanent holdings list and will buy it as soon as payday rolls around. I have 13 (lucky number) long-term stocks, and I have gone to Europe for the last 3. Ericsson was #11, Novartis is now #12. Will SAP be #13? Don't know yet, but it is looking that way. I received an annual report on Novartis that is impressive. They seem to do everything! If you saw my previous posting you know that I looked at international mutual fund holdings. I found 13 funds in which Novartis was the largest holding, 21 in which it was first or second, and 10 in which it represented 3.0% or more of a fund's holdings. The only other stocks as widely held as Novartis were Philips Electronics and Royal Dutch. So, yes, I am "in", relatively speaking. Hooray. Decisions are always easier after they are made.



To: Sonki who wrote (95)11/7/1997 12:31:00 AM
From: Tom Wilkes  Read Replies (3) | Respond to of 296
 
Checked out the relative P/Es of Pharmaceuticals. Novartis does fairly well. But comparing it to other pharmaceutical companies is a bit like oranges and apples. Novartis does too many other things. It is a great company.